Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Hill LC, Rouce RH, Wu MJ, Wang T, Ma R, Zhang H, Mehta B, Lapteva N, Mei Z, Smith TS, Yang L, Srinivasan M, Burkhardt PM, Ramos CA, Lulla P, Arredondo M, Grilley B, Heslop HE, Brenner MK, Mamonkin M.
Hill LC, et al. Among authors: heslop he.
Blood. 2024 Mar 28;143(13):1231-1241. doi: 10.1182/blood.2023022204.
Blood. 2024.
PMID: 38145560